Satellos Bioscience Inc Common Stock (MSLE) had the highest return in September 2022 by a US stock, returning 790%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Satellos Bioscience Inc Common Stock (MSLE) | September 2022 | 790% |
FingerMotion (FNGR) | September 2022 | 262.37% |
Heartbeam (BEAT) | September 2022 | 222.31% |
Immuneering (IMRX) | September 2022 | 179.69% |
Spero Therapeutics (SPRO) | September 2022 | 143.9% |
Sobr Safe (SOBR) | September 2022 | 139.29% |
Prothena (PRTA) | September 2022 | 122.66% |
Viewbix Inc Common Stock (VBIX) | September 2022 | 107.27% |
Enliven Therapeutics (ELVN) | September 2022 | 96.55% |
Pulse Biosciences (PLSE) | September 2022 | 79.69% |
Jowell Global (JWEL) | September 2022 | 78.57% |
Acumen Pharmaceuticals (ABOS) | September 2022 | 78.47% |
X4 Pharmaceuticals (XFOR) | September 2022 | 76.29% |
Vertical Aerospace (EVTL) | September 2022 | 68.65% |
Filana Therapeutics (FLNA) | September 2022 | 63.62% |
Cassava Sciences (SAVA) | September 2022 | 63.62% |
Stabilis Solutions (SLNG) | September 2022 | 62.95% |
InnovAge (INNV) | September 2022 | 61.98% |
RDE (GIFT) | September 2022 | 52.99% |
Terns Pharmaceuticals (TERN) | September 2022 | 52.2% |
EVI Industries (EVI) | September 2022 | 51.17% |
Ideaya Biosciences (IDYA) | September 2022 | 50.71% |
Cricut (CRCT) | September 2022 | 50.32% |
United Maritime (USEA) | September 2022 | 47.85% |
MetaVia (MTVA) | September 2022 | 47.68% |
